The biotechnology company officially kicked off its IPO on Wednesday.
Health Care + Med Tech
The startup’s personalized medicine test offers a unique potential in Asia, where people take similar medications to Americans and Europeans but don’t share the same genetic makeup.
The deal, according to an analyst at Leerink, would cost the Minnetonka-based insurer roughly $2.8 billion if completed.
U of M spinoff has tech to analyze microbial communities for health, ag clients.
Manufactured ‘XNA’ can bind to proteins that regulate cardiac function.
Percentage of state residents without health coverage less than half the national rate.
But he called the goal of single payer an "aspirational" one.
The state’s adult obesity rate of 27.8 percent was enough to bump it up to 34th nationally.
‘Minnesota Partnership’ seeks to develop pipeline of biotech startups, job creation.
If fundraising efforts (and an animal testing round) are successful, the founder of St. Jude Medical and Guidant said his latest startup will move forward to testing its artificial blood vessel on humans.
The company is developing treatments for gastrointestinal issues that use human gut bacteria.
The Plymouth-based company was testing a product used to treat dysfunctions in the Eustachian tube in the nose.
How health care collaboration can improve quality and cut costs.
An offbeat marketing tactic by local health care players is no more.
With this deal, the medtech giant’s total investment in Mazor could potentially grow to $125 million.
Recent U of M study shows 7.2 percent of rural hospitals have closed OB units.
Driven to Discover building is a step up in recruiting for on-site studies.
Report finds projected hike for workers far exceeds increase for their employers.